{"entity":{"type":"insider","cik":"0001861550","url":"/insider/0001861550","json_url":"/insider/0001861550.json","name":"Lorrain Daniel S.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":14,"first":"2024-11-20","last":"2026-07-10","span_basis":"filed_date"},"name_variants":[{"name":"Lorrain Daniel S.","source":"filing","n_filings":14,"first_seen":"2024-11-20","last_seen":"2026-07-10"}],"transactions":[{"id":5802704,"accession":"0001628280-26-047909","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001628280-26-047909","line_url":"/filing/0001628280-26-047909#line-4","is_derivative":false,"issuer_cik":"0001855175","issuer_name":"Contineum Therapeutics, Inc.","issuer_ticker":"CTNM","issuer_name_source":null,"issuer_url":"/issuer/0001855175","owner_cik":"0001861550","owner_name":"Lorrain Daniel S.","owner_display_name":"Lorrain Daniel S.","owner_url":"/insider/0001861550","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25.0,"shares_display":"25","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":400.0,"total_display":"400.00","total_whole":"400","shares_owned_after":135202.0,"shares_owned_after_display":"135,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-09","filed_date":"2026-07-10","scope":"insider"},{"id":5802700,"accession":"0001628280-26-047909","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-047909","line_url":"/filing/0001628280-26-047909#line-2","is_derivative":false,"issuer_cik":"0001855175","issuer_name":"Contineum Therapeutics, Inc.","issuer_ticker":"CTNM","issuer_name_source":null,"issuer_url":"/issuer/0001855175","owner_cik":"0001861550","owner_name":"Lorrain Daniel S.","owner_display_name":"Lorrain Daniel S.","owner_url":"/insider/0001861550","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1015.0,"shares_display":"1,015","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":16240.0,"total_display":"16,240.00","total_whole":"16,240","shares_owned_after":135202.0,"shares_owned_after_display":"135,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-08","filed_date":"2026-07-10","scope":"insider"},{"id":5885070,"accession":"0001628280-26-047058","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001628280-26-047058","line_url":"/filing/0001628280-26-047058","is_derivative":false,"issuer_cik":"0001855175","issuer_name":"Contineum Therapeutics, Inc.","issuer_ticker":"CTNM","issuer_name_source":null,"issuer_url":"/issuer/0001855175","owner_cik":"0001861550","owner_name":"Lorrain Daniel S.","owner_display_name":"Lorrain Daniel S.","owner_url":"/insider/0001861550","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8353.0,"shares_display":"8,353","price_per_share":15.837425511792171,"price_display":"15.84","price_state":"stated","total_value":132290.0153,"total_display":"132,290.02","total_whole":"132,290","shares_owned_after":137703.0,"shares_owned_after_display":"137,703","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-01","filed_date":"2026-07-02","scope":"insider","n_lines":2},{"id":5885065,"accession":"0001628280-26-047058","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-047058","line_url":"/filing/0001628280-26-047058#line-2","is_derivative":false,"issuer_cik":"0001855175","issuer_name":"Contineum Therapeutics, Inc.","issuer_ticker":"CTNM","issuer_name_source":null,"issuer_url":"/issuer/0001855175","owner_cik":"0001861550","owner_name":"Lorrain Daniel S.","owner_display_name":"Lorrain Daniel S.","owner_url":"/insider/0001861550","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28826.0,"shares_display":"28,826","price_per_share":16.0372,"price_display":"16.04","price_state":"stated","total_value":462288.3272,"total_display":"462,288.33","total_whole":"462,288","shares_owned_after":139372.0,"shares_owned_after_display":"139,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-30","filed_date":"2026-07-02","scope":"insider"},{"id":6219551,"accession":"0001628280-26-039641","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-039641","line_url":"/filing/0001628280-26-039641#line-1","is_derivative":false,"issuer_cik":"0001855175","issuer_name":"Contineum Therapeutics, Inc.","issuer_ticker":"CTNM","issuer_name_source":null,"issuer_url":"/issuer/0001855175","owner_cik":"0001861550","owner_name":"Lorrain Daniel S.","owner_display_name":"Lorrain Daniel S.","owner_url":"/insider/0001861550","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4170.0,"shares_display":"4,170","price_per_share":13.1564,"price_display":"13.16","price_state":"stated","total_value":54862.188,"total_display":"54,862.19","total_whole":"54,862","shares_owned_after":139372.0,"shares_owned_after_display":"139,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-01","scope":"insider"},{"id":6219247,"accession":"0001628280-26-029435","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-029435","line_url":"/filing/0001628280-26-029435","is_derivative":false,"issuer_cik":"0001855175","issuer_name":"Contineum Therapeutics, Inc.","issuer_ticker":"CTNM","issuer_name_source":null,"issuer_url":"/issuer/0001855175","owner_cik":"0001861550","owner_name":"Lorrain Daniel S.","owner_display_name":"Lorrain Daniel S.","owner_url":"/insider/0001861550","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4170.0,"shares_display":"4,170","price_per_share":13.11611510791367,"price_display":"13.12","price_state":"stated","total_value":54694.2,"total_display":"54,694.20","total_whole":"54,694","shares_owned_after":143842.0,"shares_owned_after_display":"143,842","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-01","filed_date":"2026-05-01","scope":"insider","n_lines":2},{"id":5814451,"accession":"0001628280-26-023949","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-023949","line_url":"/filing/0001628280-26-023949#line-1","is_derivative":false,"issuer_cik":"0001855175","issuer_name":"Contineum Therapeutics, Inc.","issuer_ticker":"CTNM","issuer_name_source":null,"issuer_url":"/issuer/0001855175","owner_cik":"0001861550","owner_name":"Lorrain Daniel S.","owner_display_name":"Lorrain Daniel S.","owner_url":"/insider/0001861550","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4170.0,"shares_display":"4,170","price_per_share":13.4326,"price_display":"13.43","price_state":"stated","total_value":56013.942,"total_display":"56,013.94","total_whole":"56,014","shares_owned_after":147712.0,"shares_owned_after_display":"147,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-06","filed_date":"2026-04-06","scope":"insider"},{"id":5844099,"accession":"0001437749-26-006422","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-26-006422","line_url":"/filing/0001437749-26-006422#line-1","is_derivative":false,"issuer_cik":"0001855175","issuer_name":"Contineum Therapeutics, Inc.","issuer_ticker":"CTNM","issuer_name_source":null,"issuer_url":"/issuer/0001855175","owner_cik":"0001861550","owner_name":"Lorrain Daniel S.","owner_display_name":"Lorrain Daniel S.","owner_url":"/insider/0001861550","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4170.0,"shares_display":"4,170","price_per_share":15.0084,"price_display":"15.01","price_state":"stated","total_value":62585.028,"total_display":"62,585.03","total_whole":"62,585","shares_owned_after":151882.0,"shares_owned_after_display":"151,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-02","scope":"insider"},{"id":6037735,"accession":"0001437749-26-005889","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001437749-26-005889","line_url":"/filing/0001437749-26-005889#line-4","is_derivative":false,"issuer_cik":"0001855175","issuer_name":"Contineum Therapeutics, Inc.","issuer_ticker":"CTNM","issuer_name_source":null,"issuer_url":"/issuer/0001855175","owner_cik":"0001861550","owner_name":"Lorrain Daniel S.","owner_display_name":"Lorrain Daniel S.","owner_url":"/insider/0001861550","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3824.0,"shares_display":"3,824","price_per_share":16.0115,"price_display":"16.01","price_state":"stated","total_value":61227.976,"total_display":"61,227.98","total_whole":"61,228","shares_owned_after":156052.0,"shares_owned_after_display":"156,052","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-25","filed_date":"2026-02-26","scope":"insider"},{"id":6037731,"accession":"0001437749-26-005889","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-26-005889","line_url":"/filing/0001437749-26-005889#line-2","is_derivative":false,"issuer_cik":"0001855175","issuer_name":"Contineum Therapeutics, Inc.","issuer_ticker":"CTNM","issuer_name_source":null,"issuer_url":"/issuer/0001855175","owner_cik":"0001861550","owner_name":"Lorrain Daniel S.","owner_display_name":"Lorrain Daniel S.","owner_url":"/insider/0001861550","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4300.0,"shares_display":"4,300","price_per_share":16.0316,"price_display":"16.03","price_state":"stated","total_value":68935.88,"total_display":"68,935.88","total_whole":"68,936","shares_owned_after":156052.0,"shares_owned_after_display":"156,052","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-24","filed_date":"2026-02-26","scope":"insider"},{"id":6147587,"accession":"0001437749-26-004912","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-26-004912","line_url":"/filing/0001437749-26-004912#line-2","is_derivative":false,"issuer_cik":"0001855175","issuer_name":"Contineum Therapeutics, Inc.","issuer_ticker":"CTNM","issuer_name_source":null,"issuer_url":"/issuer/0001855175","owner_cik":"0001861550","owner_name":"Lorrain Daniel S.","owner_display_name":"Lorrain Daniel S.","owner_url":"/insider/0001861550","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":1600.0,"total_display":"1,600.00","total_whole":"1,600","shares_owned_after":156052.0,"shares_owned_after_display":"156,052","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-19","filed_date":"2026-02-20","scope":"insider"},{"id":5870917,"accession":"0001437749-26-004122","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-26-004122","line_url":"/filing/0001437749-26-004122#line-2","is_derivative":false,"issuer_cik":"0001855175","issuer_name":"Contineum Therapeutics, Inc.","issuer_ticker":"CTNM","issuer_name_source":null,"issuer_url":"/issuer/0001855175","owner_cik":"0001861550","owner_name":"Lorrain Daniel S.","owner_display_name":"Lorrain Daniel S.","owner_url":"/insider/0001861550","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":6400.0,"total_display":"6,400.00","total_whole":"6,400","shares_owned_after":156052.0,"shares_owned_after_display":"156,052","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-11","filed_date":"2026-02-13","scope":"insider"},{"id":5783466,"accession":"0001437749-26-003212","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-26-003212","line_url":"/filing/0001437749-26-003212","is_derivative":false,"issuer_cik":"0001855175","issuer_name":"Contineum Therapeutics, Inc.","issuer_ticker":"CTNM","issuer_name_source":null,"issuer_url":"/issuer/0001855175","owner_cik":"0001861550","owner_name":"Lorrain Daniel S.","owner_display_name":"Lorrain Daniel S.","owner_url":"/insider/0001861550","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4170.0,"shares_display":"4,170","price_per_share":14.941358992805755,"price_display":"14.94","price_state":"stated","total_value":62305.467,"total_display":"62,305.47","total_whole":"62,305","shares_owned_after":157222.0,"shares_owned_after_display":"157,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-03","filed_date":"2026-02-05","scope":"insider","n_lines":2},{"id":5932076,"accession":"0001437749-26-000616","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-26-000616","line_url":"/filing/0001437749-26-000616","is_derivative":false,"issuer_cik":"0001855175","issuer_name":"Contineum Therapeutics, Inc.","issuer_ticker":"CTNM","issuer_name_source":null,"issuer_url":"/issuer/0001855175","owner_cik":"0001861550","owner_name":"Lorrain Daniel S.","owner_display_name":"Lorrain Daniel S.","owner_url":"/insider/0001861550","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4170.0,"shares_display":"4,170","price_per_share":10.442005035971222,"price_display":"10.44","price_state":"stated","total_value":43543.161,"total_display":"43,543.16","total_whole":"43,543","shares_owned_after":160722.0,"shares_owned_after_display":"160,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-06","scope":"insider","n_lines":2},{"id":4079827,"accession":"0001437749-25-038936","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-25-038936","line_url":"/filing/0001437749-25-038936#line-1","is_derivative":false,"issuer_cik":"0001855175","issuer_name":"Contineum Therapeutics, Inc.","issuer_ticker":"CTNM","issuer_name_source":null,"issuer_url":"/issuer/0001855175","owner_cik":"0001861550","owner_name":"Lorrain Daniel S.","owner_display_name":"Lorrain Daniel S.","owner_url":"/insider/0001861550","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4170.0,"shares_display":"4,170","price_per_share":12.2324,"price_display":"12.23","price_state":"stated","total_value":51009.108,"total_display":"51,009.11","total_whole":"51,009","shares_owned_after":164392.0,"shares_owned_after_display":"164,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-23","filed_date":"2025-12-30","scope":"insider"},{"id":2216519,"accession":"0001437749-24-036349","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-24-036349","line_url":"/filing/0001437749-24-036349#line-1","is_derivative":false,"issuer_cik":"0001855175","issuer_name":"Contineum Therapeutics, Inc.","issuer_ticker":"CTNM","issuer_name_source":null,"issuer_url":"/issuer/0001855175","owner_cik":"0001861550","owner_name":"Lorrain Daniel S.","owner_display_name":"Lorrain Daniel S.","owner_url":"/insider/0001861550","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1010.0,"shares_display":"1,010","price_per_share":16.0172,"price_display":"16.02","price_state":"stated","total_value":16177.372,"total_display":"16,177.37","total_whole":"16,177","shares_owned_after":168562.0,"shares_owned_after_display":"168,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-25","filed_date":"2024-11-27","scope":"insider"},{"id":2332991,"accession":"0001437749-24-035887","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-24-035887","line_url":"/filing/0001437749-24-035887","is_derivative":false,"issuer_cik":"0001855175","issuer_name":"Contineum Therapeutics, Inc.","issuer_ticker":"CTNM","issuer_name_source":null,"issuer_url":"/issuer/0001855175","owner_cik":"0001861550","owner_name":"Lorrain Daniel S.","owner_display_name":"Lorrain Daniel S.","owner_url":"/insider/0001861550","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6190.0,"shares_display":"6,190","price_per_share":16.384614830371568,"price_display":"16.38","price_state":"stated","total_value":101420.7658,"total_display":"101,420.77","total_whole":"101,421","shares_owned_after":169671.0,"shares_owned_after_display":"169,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-18","filed_date":"2024-11-20","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":22,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":22,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":22},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001855175","name":"Contineum Therapeutics, Inc.","url":"/issuer/0001855175","role":"Officer (Chief Scientific Officer)","n_filings":14,"first_seen":"2024-11-20","last_seen":"2026-07-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001861550","retrieved_at":"2026-08-25T04:21:21+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}